PharmaNutra
Carlo Volpi is an experienced professional with a background in various industries such as pharmaceuticals, consulting, and retail. Currently serving as the COO at PharmaNutra SpA, Carlo has demonstrated strong leadership and management skills in previous roles such as CEO at Vertigo Partners Srl and Step SpA. With a strong educational background from the London Business School and Università degli Studi di Parma, Carlo has a solid foundation in management, strategy, finance, and business development.
This person is not in any offices
PharmaNutra
1 followers
PharmaNutra is a group of Italian companies based in Pisa, specialising in the pharmaceutical and nutraceutical sector. The Group includes three companies: PharmaNutra S.p.A., Junia Pharma S.r.l. and Alesco S.r.l. The history of the PharmaNutra Group was founded from the vision of two brothers, Andrea and Roberto Lacorte, who, in the early 2000s, decided to put together their scientific and commercial insights to change the way people approach health and well-being. The PharmaNutra Group is currently one of the most appreciated Italian companies in the pharmaceutical and nutraceutical sector, thanks to products made with innovative and patented technologies. A forward-looking business, strengthened by a continuous and increasingly intense R&D activities and a constant overseas expansion. A business capable of growing and establishing itself also in the field of sport, through sponsorships of excellence, with the full awareness that at the base of every company, there must be strong financial soundness. The know-how acquired in years of scientific research, clinical trials and publications has allowed the Group’s companies to obtain: 17 Proprietary raw materials 19 Patents filed 39 Registered trademarks 134 Clinical studies and basic research Working at PharmaNutra means becoming part of a team that is strongly goal-oriented and always ready for new challenges. We believe in talent, but even more so in commitment and willpower, since a company’s success is based on the value of its people.